Imaging of differentiated thyroid carcinoma: 124I-PET/MRI may not be superior to 124I-PET/CT

被引：3
|
作者：
Binse, Ina [1 ]
Rosenbaum-Krumme, Sandra Julia [1 ]
Bockisch, Andreas [1 ]
机构：
[1] Univ Duisburg Essen, Dept Nucl Med, Hufelandstr 55, D-45122 Essen, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2016年 / 43卷 / 06期
关键词：
Differentiate Thyroid Carcinoma; High Detection Rate; Radioiodine Uptake; 124I Uptake; Combine Reading;
D O I：
10.1007/s00259-016-3321-9
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1185 / 1186
页数：2
相关论文
共 50 条
  • [41] The effectiveness of 124I PET/CT in patients with differentiated thyroid cancer
    Capoccetti, F.
    Criscuoli, B.
    Rossi, G.
    Ferretti, F.
    Manni, C.
    Brianzoni, E.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 53 (05): : 536 - 545
  • [42] Effects of Rosiglitazone on Radioiodine Negative and Progressive Differentiated Thyroid Carcinoma as Assessed by 124I PET/CT Imaging
    Rosenbaum-Krumme, Sandra Julia
    Freudenberg, Lutz Stefan
    Jentzen, Walter
    Bockisch, Andreas
    Nagarajah, James
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (03) : E47 - E52
  • [43] Implementation, validation, and optimization of 124I-PET Monte Carlo patient specific dosimetry in radioiodine therapy
    Braad, Poul-Erik
    Hansen, Saren
    Xie, Tianwu
    Zaidi, Habib
    Hoilund-Carlsen, Poul Flemming
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [44] Radioiodine therapy guided by 124I-PET/CT in metastatic DTC: long-term follow-up data
    Lodi Rizzini, E.
    Allegri, V.
    Zanoni, L.
    Tabacchi, E.
    Laghi, V.
    Strigari, L.
    Repaci, A.
    Scampoli, C.
    Vallerossa, D.
    Deraco, E.
    Cavallini, L.
    Bertini, F.
    Cammelli, S.
    Frezza, G. P.
    Morganti, A. G.
    Fanti, S.
    Monari, F.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S855 - S856
  • [45] Diagnosis of de quervain's subacute thyroiditis via sensor-navigated 124Iodine PET/ultrasound (124I-PET/US) fusion
    Freesmeyer, Martin
    Opfermann, Thomas
    ENDOCRINE, 2015, 49 (01) : 293 - 295
  • [46] Diagnosis of de quervain’s subacute thyroiditis via sensor-navigated 124Iodine PET/ultrasound (124I-PET/US) fusion
    Martin Freesmeyer
    Thomas Opfermann
    Endocrine, 2015, 49 : 293 - 295
  • [47] Radioiodine therapy (RAIT) guided by 124I-PET/CT imaging in metastatic differentiated thyroid cancer (DTC): long-term follow-up of patients recruited in a prospective trial
    Rizzini, E. Lodi
    Pettinato, C.
    Zanoni, L.
    Allegri, V.
    Tabacchi, E.
    Repaci, A.
    Morganti, A. G.
    Fanti, S.
    Monari, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S30 - S30
  • [48] The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancer
    Weber, Manuel
    Binse, Ina
    Nagarajah, James
    Bockisch, Andreas
    Herrmann, Ken
    Jentzen, Walter
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 63 (03): : 235 - 252
  • [49] 124I PET/CT in the pretherapeutic staging of differentiated thyroid carcinoma: comparison with posttherapy 131I SPECT/CT
    de Pont, Cecile
    Halders, Servais
    Bucerius, Jan
    Mottaghy, Felix
    Brans, Boudewijn
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (05) : 693 - 700
  • [50] 124I PET/CT in the pretherapeutic staging of differentiated thyroid carcinoma: comparison with posttherapy 131I SPECT/CT
    Cecile de Pont
    Servais Halders
    Jan Bucerius
    Felix Mottaghy
    Boudewijn Brans
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 693 - 700
12345